Clinical Trial Update: Optimal Combination of Adjuvant Radiotherapy and Immunotherapy for Breast Cancer

View source ↗

Summary

This update covers a clinical trial evaluating the optimal combination of adjuvant radiotherapy and immunotherapy for breast cancer, including triple-negative b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Hypofractionated Radiotherapy, Triple Negative Breast Cancer (TNBC) | Status: ACTIVE_NOT_RECRUITING